Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infertility in Males01:23

Infertility in Males

255
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
255
Oogenesis02:07

Oogenesis

63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K
Spermatogenesis01:41

Spermatogenesis

102.3K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalized Management of Non-Obstructive Azoospermia: Current Evidence, Clinical Strategies, and Future Directions.

The world journal of men's health·2026
Same author

NATURal history of coronary PlaquE on cardiac computed tomography in individuals without MACE or lipid-lowering therapy: NATURE-CTstudy.

Journal of cardiovascular computed tomography·2026
Same author

Ten Years of Tubes: Characterizing Delays in Definitive Management of Benign Ureteral Obstruction.

Journal of endourology·2026
Same author

Management of Non-Obstructive Azoospermia: Practical Answers to Key Clinical Questions.

The world journal of men's health·2026
Same author

Authorship Accountability and Transparency: A Standardized Model from the Global Andrology Forum.

The world journal of men's health·2026
Same author

Global Andrology Forum Clinical Guidelines on Antioxidant Use in the Treatment of Male Infertility.

The world journal of men's health·2026

Related Experiment Video

Updated: Jun 13, 2025

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia
06:28

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia

Published on: May 27, 2022

3.7K

Differentiation between nonobstructive azoospermia and obstructive azoospermia: then and now.

Logan Hubbard1, Amarnath Rambhatla1, Giovanni M Colpi2

  • 1Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI 48202-3450, USA.

Asian Journal of Andrology
|September 13, 2024
PubMed
Summary

Azoospermia affects 10%-15% of infertile men. This review aids physicians in differentiating obstructive azoospermia (OA) from nonobstructive azoospermia (NOA) for improved male infertility management.

Keywords:
male factor infertilitynonobstructive azoospermiaobstructive azoospermia

More Related Videos

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

692
Clinical Application of 24 G Cannula Needle and 3-0 Polypropylene Suture in Vas Deferens Exploration
07:21

Clinical Application of 24 G Cannula Needle and 3-0 Polypropylene Suture in Vas Deferens Exploration

Published on: February 10, 2023

2.6K

Related Experiment Videos

Last Updated: Jun 13, 2025

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia
06:28

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia

Published on: May 27, 2022

3.7K
Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

692
Clinical Application of 24 G Cannula Needle and 3-0 Polypropylene Suture in Vas Deferens Exploration
07:21

Clinical Application of 24 G Cannula Needle and 3-0 Polypropylene Suture in Vas Deferens Exploration

Published on: February 10, 2023

2.6K

Area of Science:

  • Reproductive Medicine
  • Urology
  • Andrology

Background:

  • Male infertility is a growing concern, with azoospermia affecting 10%-15% of infertile men.
  • Azoospermia requires differentiation between obstructive (OA) and nonobstructive (NOA) types.
  • OA accounts for 20%-40% of azoospermia cases, necessitating accurate diagnosis.

Purpose of the Study:

  • To provide a diagnostic framework for distinguishing between OA and NOA.
  • To synthesize current guidelines and literature for reproductive physicians.
  • To enhance the management of infertile couples through accurate azoospermia classification.

Main Methods:

  • Comprehensive literature review.
  • Analysis of current clinical guidelines.
  • Synthesis of diagnostic strategies for azoospermia.

Main Results:

  • Identification of key differentiating factors between OA and NOA.
  • Compilation of a diagnostic armamentarium for physicians.
  • Emphasis on the clinical implications of accurate diagnosis.

Conclusions:

  • Accurate differentiation between OA and NOA is crucial for effective male infertility management.
  • This review equips physicians with tools to diagnose azoospermia subtypes.
  • Improved diagnostic capabilities lead to better care for infertile couples.